| Brett Patrick Godbout, MD | |
|
2775 Schoenersville Rd, Bethlehem, PA 18017-7307 | |
| (610) 861-8080 | |
| (610) 807-0366 |
| Full Name | Brett Patrick Godbout |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 2775 Schoenersville Rd, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184621948 | NPI | - | NPPES |
| 0427799000 | Other | AMERIHEALTH | |
| 1353362 | Other | CIGNA HEALTHCARE | |
| 328815 | Other | HEALTH AMERICA/HEALTH ASS | |
| 0427799000 | Other | KEYSTONE HEALTH EAST | |
| 1459385 | Other | PRIVATE HEALTHCARE SYSTEM | |
| 605276 | Other | FIRST PRIORITY LIFE INS. | |
| 819550 | Other | FIRST PRIORITY HEALTH | |
| 0012062330001 | Medicaid | PA | |
| 200007508 | Other | RAILROAD MEDICARE | |
| 328815 | Other | HIGHMARK BLUE SHIELD | |
| 01195901 | Other | KEYSTONE HEALTH CENTRAL | |
| 088884 | Other | AETNA | |
| 2170505 | Other | MAMSI | |
| 0427799000 | Other | INDEPENDENCE BLUE CROSS | |
| 50044348 | Other | CAPITAL BLUE CROSS | |
| 13294 | Other | GEISINGER HEALTH PLAN | |
| 1553795 | Other | UNITED HEALTHCARE | |
| P379431 | Other | OXFORD HEALTH PLANS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD041621L (Pennsylvania) | Primary |
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Pharma Two B announced today that enrollment has been completed in the company's Phase IIb study of P2B001 for the treatment of early stage Parkinson's disease. One hundred and forty-nine patients enrolled in the study conducted at 29 clinical sites throughout the US and Israel.
Alliant Pharmaceuticals has announced FDA approval of Methylin Chewable Tablets and Methylin Oral Solution for the treatment of ADHD. The two products are the first, and only, chewable tablet and oral solution for ADHD to gain FDA acceptance.
Patients undergoing colon and rectal operations who participated in an innovative quality improvement (QI) program to speed their recovery and enhance results experienced shorter hospitalizations, reduced infection rates, and lower hospital costs, according to new study results.
Like tobacco smoking, marijuana smoking has been implicated as a causative factor in tumors of the head and neck and of the lung.
Tolero Pharmaceuticals and MannKind Corporation today announced a license agreement granting Tolero exclusive worldwide rights to develop and commercialize compounds from MannKind's novel BTK (Bruton's tyrosine kinase) program, which are currently being developed for the treatment of hematological malignancies and inflammatory diseases.
› Verified 3 days ago
| Entity Name | Chs Professional Practice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710987417 PECOS PAC ID: 4880591288 Enrollment ID: O20040521000334 |
News Archive
Pharma Two B announced today that enrollment has been completed in the company's Phase IIb study of P2B001 for the treatment of early stage Parkinson's disease. One hundred and forty-nine patients enrolled in the study conducted at 29 clinical sites throughout the US and Israel.
Alliant Pharmaceuticals has announced FDA approval of Methylin Chewable Tablets and Methylin Oral Solution for the treatment of ADHD. The two products are the first, and only, chewable tablet and oral solution for ADHD to gain FDA acceptance.
Patients undergoing colon and rectal operations who participated in an innovative quality improvement (QI) program to speed their recovery and enhance results experienced shorter hospitalizations, reduced infection rates, and lower hospital costs, according to new study results.
Like tobacco smoking, marijuana smoking has been implicated as a causative factor in tumors of the head and neck and of the lung.
Tolero Pharmaceuticals and MannKind Corporation today announced a license agreement granting Tolero exclusive worldwide rights to develop and commercialize compounds from MannKind's novel BTK (Bruton's tyrosine kinase) program, which are currently being developed for the treatment of hematological malignancies and inflammatory diseases.
› Verified 3 days ago
| Entity Name | Hazleton Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952464638 PECOS PAC ID: 8022110402 Enrollment ID: O20070305000195 |
News Archive
Pharma Two B announced today that enrollment has been completed in the company's Phase IIb study of P2B001 for the treatment of early stage Parkinson's disease. One hundred and forty-nine patients enrolled in the study conducted at 29 clinical sites throughout the US and Israel.
Alliant Pharmaceuticals has announced FDA approval of Methylin Chewable Tablets and Methylin Oral Solution for the treatment of ADHD. The two products are the first, and only, chewable tablet and oral solution for ADHD to gain FDA acceptance.
Patients undergoing colon and rectal operations who participated in an innovative quality improvement (QI) program to speed their recovery and enhance results experienced shorter hospitalizations, reduced infection rates, and lower hospital costs, according to new study results.
Like tobacco smoking, marijuana smoking has been implicated as a causative factor in tumors of the head and neck and of the lung.
Tolero Pharmaceuticals and MannKind Corporation today announced a license agreement granting Tolero exclusive worldwide rights to develop and commercialize compounds from MannKind's novel BTK (Bruton's tyrosine kinase) program, which are currently being developed for the treatment of hematological malignancies and inflammatory diseases.
› Verified 3 days ago
| Entity Name | Lvhn Coordinated Professional Practice |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366082554 PECOS PAC ID: 2163851858 Enrollment ID: O20200331003752 |
News Archive
Pharma Two B announced today that enrollment has been completed in the company's Phase IIb study of P2B001 for the treatment of early stage Parkinson's disease. One hundred and forty-nine patients enrolled in the study conducted at 29 clinical sites throughout the US and Israel.
Alliant Pharmaceuticals has announced FDA approval of Methylin Chewable Tablets and Methylin Oral Solution for the treatment of ADHD. The two products are the first, and only, chewable tablet and oral solution for ADHD to gain FDA acceptance.
Patients undergoing colon and rectal operations who participated in an innovative quality improvement (QI) program to speed their recovery and enhance results experienced shorter hospitalizations, reduced infection rates, and lower hospital costs, according to new study results.
Like tobacco smoking, marijuana smoking has been implicated as a causative factor in tumors of the head and neck and of the lung.
Tolero Pharmaceuticals and MannKind Corporation today announced a license agreement granting Tolero exclusive worldwide rights to develop and commercialize compounds from MannKind's novel BTK (Bruton's tyrosine kinase) program, which are currently being developed for the treatment of hematological malignancies and inflammatory diseases.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brett Patrick Godbout, MD 1605 N Cedar Crest Blvd Ste 411, Allentown, PA 18104-2323 Ph: (484) 884-4500 | Brett Patrick Godbout, MD 2775 Schoenersville Rd, Bethlehem, PA 18017-7307 Ph: (610) 861-8080 |
News Archive
Pharma Two B announced today that enrollment has been completed in the company's Phase IIb study of P2B001 for the treatment of early stage Parkinson's disease. One hundred and forty-nine patients enrolled in the study conducted at 29 clinical sites throughout the US and Israel.
Alliant Pharmaceuticals has announced FDA approval of Methylin Chewable Tablets and Methylin Oral Solution for the treatment of ADHD. The two products are the first, and only, chewable tablet and oral solution for ADHD to gain FDA acceptance.
Patients undergoing colon and rectal operations who participated in an innovative quality improvement (QI) program to speed their recovery and enhance results experienced shorter hospitalizations, reduced infection rates, and lower hospital costs, according to new study results.
Like tobacco smoking, marijuana smoking has been implicated as a causative factor in tumors of the head and neck and of the lung.
Tolero Pharmaceuticals and MannKind Corporation today announced a license agreement granting Tolero exclusive worldwide rights to develop and commercialize compounds from MannKind's novel BTK (Bruton's tyrosine kinase) program, which are currently being developed for the treatment of hematological malignancies and inflammatory diseases.
› Verified 3 days ago
Christopher Richard Ferrante, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2775 Schoenersville Rd, Bethlehem, PA 18017 Phone: 610-861-8080 | |
Samantha Nicole Weiss, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 801 Ostrum St Ste 1, Bethlehem, PA 18015 Phone: 856-669-1341 | |
Dr. William Jerome Vostinak, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2649 Schoenersville Rd, Suite 102, Bethlehem, PA 18017 Phone: 484-884-2249 | |
Dr. Michael Frederick Busch, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2775 Schoenersville Rd, Bethlehem, PA 18017 Phone: 610-861-8080 Fax: 610-807-0366 | |
Gregory F Carolan, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Pphp2, Bethlehem, PA 18015 Phone: 484-526-1735 Fax: 484-526-2429 | |
Dr. Maheep Pratap Vikram, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Pphp2, Bethlehem, PA 18015 Phone: 484-526-1735 Fax: 484-526-2429 | |
James Michael Sacco, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Pphp2, Bethlehem, PA 18015 Phone: 610-954-1735 Fax: 610-954-2492 |